CJ Bioscience, Inc.

A311690

KR7311690002

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
14,790 ^KRW	+3.14%		+7.10%	-8.36%

2023	CJ Bioscience, Inc. announced that it has received KRW 24.033 billion in funding from CJ Cheiljedang Corporation	CI
2023	CJ Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI

ChunLab, Inc. has completed an IPO in the amount of KRW 17.2 billion.

December 25, 2019 at 12:00 am EST

ChunLab, Inc. has completed an IPO in the amount of KRW 17.2 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 430,000 PriceRange: KRW 40000

Latest news about CJ Bioscience, Inc.

CJ Bioscience, Inc. announced that it has received KRW 24.033 billion in funding from CJ Cheiljedang Corporation	23-08-09	CI
CJ Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Provectus Algae Pty Ltd announced that it has received funding from CJ Bioscience, Inc.	23-02-28	CI
CJ Bioscience, Inc. agreed to acquire Red BIO business of CJ Cheiljedang Corporation for KRW 6.1 billion.	21-11-07	CI
CJ Cheiljedang Corporation completed the acquisition of 15.99% stake in ChunLab, Inc. from Jong-sik Cheon and Shanghai ZJ Bio-Tech Co., Ltd..	21-10-28	CI
ChunLab, Inc. announced that it has received KRW 73.24122766 billion in funding from CJ Cheiljedang Corporation	21-10-28	CI
CJ Cheiljedang Corporation signed a stock purchase contract to acquire 15.99% stake in ChunLab, Inc. from Jong-sik Cheon and Shanghai ZJ Bio-Tech Co., Ltd. for KRW 25 billion.	21-07-20	CI
ChunLab, Inc. announced that it expects to receive KRW 73.24122766 billion in funding from CJ Cheiljedang Corporation	21-07-20	CI
ChunLab, Inc. announced that it has received KRW 30 billion in funding	20-09-01	CI
ChunLab, Inc. announced that it expects to receive KRW 30 billion in funding	20-08-30	CI
ChunLab, Inc. has completed an IPO in the amount of KRW 17.2 billion.	19-12-25	CI
ChunLab Releases Beta Version of TrueBac ID, the Genome-Based Diagnostic Solution for Bacterial Identification	19-09-05	CI
ChunLab, Inc. has filed an IPO.	19-09-05	CI

CJ Bioscience Inc, formerly ChunLab Inc, is a Korea-based company principally engaged in the provision of microbial bioinformatics platform and solutions. The Company mainly provides microbial bioinformatics analysis services and microbiome-based healthcare services through bioinformatics database and cloud analytics platform. The Company also develops microbiome therapies and infection diagnosis solutions.

Sector

Biotechnology & Medical Research

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
CJ BIOSCIENCE, INC.	-8.36%	97.38M
IQVIA HOLDINGS INC.	+0.67%	42.19B
LONZA GROUP AG	+44.30%	40.15B
CELLTRION, INC.	-6.20%	28.31B
ICON PUBLIC LIMITED COMPANY	+6.55%	24.63B
ALNYLAM PHARMACEUTICALS, INC.	-21.66%	18.2B
MEDPACE HOLDINGS, INC.	+29.96%	12.01B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.57%	11.76B
UNITED THERAPEUTICS CORPORATION	+16.03%	10.4B
BIO-TECHNE CORPORATION	-4.80%	9.94B